Low-dose oral enoximone enhances the ability to wean patients with ultra-advanced heart failure from intravenous inotropic support: results of the oral enoximone in intravenous inotrope-dependent subjects trial.

Feldman, Am; Oren, Rm; Abraham, Wt; Boehmer, Jp; Carson, Pe; Eichhorn, E; Gilbert, Em; Kao, A; Leier, Cv; Lowes, Bd; Mathier, Ma; Mcgrew, Fa; Metra, Marco; Zisman, Ls; Shakar, Sf; Krueger, Sk; Robertson, Ad; White, Bg; Gerber, Mj; Wold, Ge; Bristow, Mr; EMOTE Study, Group